ESC Premium Access

Cardiovascular drugs in acute coronary syndromes: when to start and when to stop

Event: ESC CONGRESS 2019
Topic: Pharmacology and Pharmacotherapy
Session type: Symposium
Date: 2 September 2019
Time: 08:30 - 10:00

Congress Session

4 presentations in this session

When to start and when to stop P2Y12 inhibitors in acute coronary syndromes

Speaker: Doctor D. Angiolillo (Jacksonville, US)
Thumbnail

When to start and when to stop beta-blockers in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Professor E. Puymirat (Paris, FR)
Thumbnail

When to start and when to stop ACE-I/ARB in acute coronary syndromes and (nearly) normal ventricular function

Speaker: Doctor B. Gersh (Rochester, US)
Thumbnail

Early administration of lipid lowering agents in acute coronary syndromes.

Speaker: Professor C. Cannon (Boston, US)
Thumbnail

4 speakers from this session

Doctor Dominick Joseph Angiolillo

University of Florida College of Medicine, Jacksonville (United States of America)
23 presentations
1 follower

Professor Etienne Puymirat

European Hospital Georges Pompidou, Paris (France)
2 presentations
0 follower

Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)
5 presentations
0 follower

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

This platform is supported by

logo Novo Nordisk